Covered recipient · General Payments record
MANINDER SINGH AULAKH
Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry
General Payments · PY2024
$705.32
- Reported across 30 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $705.32 | 30 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $337.77 | 14 |
| Indivior Inc. | $157.83 | 6 |
| Janssen Pharmaceuticals, Inc | $74.68 | 4 |
| Teva Pharmaceuticals USA, Inc. | $53.58 | 3 |
| Neurocrine BioSciences, Inc. | $30.24 | 1 |
| Alkermes, Inc. | $26.49 | 1 |
| Axsome Therapeutics, Inc. | $24.73 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2024 | $705.32 | 30 |
Payment records · PY2024 (30)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $18.55 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103251991 | CMS |
| ABBVIE INC. | $17.83 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103251993 | CMS |
| ABBVIE INC. | $16.52 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103251995 | CMS |
| ABBVIE INC. | $16.46 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103251997 | CMS |
| ABBVIE INC. | $17.09 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103251999 | CMS |
| ABBVIE INC. | $21.17 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103252001 | CMS |
| ABBVIE INC. | $13.54 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103252003 | CMS |
| ABBVIE INC. | $125.00 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103252005 | CMS |
| ABBVIE INC. | $21.42 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103252007 | CMS |
| ABBVIE INC. | $14.50 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103252009 | CMS |
| ABBVIE INC. | $4.58 | 09/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103252011 | CMS |
| ABBVIE INC. | $20.22 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103252013 | CMS |
| ABBVIE INC. | $15.73 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103252015 | CMS |
| ABBVIE INC. | $15.16 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103252017 | CMS |
| Alkermes, Inc. | $26.49 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120460437 | CMS |
| Axsome Therapeutics, Inc. | $24.73 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148300430 | CMS |
| Indivior Inc. | $24.98 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144523757 | CMS |
| Indivior Inc. | $26.27 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144523759 | CMS |
| Indivior Inc. | $29.20 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144523761 | CMS |
| Indivior Inc. | $28.34 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144523763 | CMS |
| Indivior Inc. | $23.62 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144523765 | CMS |
| Indivior Inc. | $25.42 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144523767 | CMS |
| Janssen Pharmaceuticals, Inc | $20.52 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077967486 | CMS |
| Janssen Pharmaceuticals, Inc | $18.38 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077969108 | CMS |
| Janssen Pharmaceuticals, Inc | $18.60 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077968230 | CMS |
| Janssen Pharmaceuticals, Inc | $17.18 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077969088 | CMS |
| Neurocrine Biosciences, Inc. | $30.24 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150825518 | CMS |
| Teva Pharmaceuticals USA, Inc. | $15.86 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151678331 | CMS |
| Teva Pharmaceuticals USA, Inc. | $16.43 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151678419 | CMS |
| Teva Pharmaceuticals USA, Inc. | $21.29 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151678499 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2024
- Source files
- Dataset page · Bulk file · PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.